Rocket One (RKTO) Stock Soars 24% Following SpaceXAI API Program Acceptance

Key Takeaways

• Rocket One (RKTO) secured entry into SpaceXAI’s API program, unlocking access to advanced multimodal AI capabilities
• Shares rallied approximately 24% following the announcement, reaching $0.80 with a $15.35 million market capitalization
• The API access encompasses AI systems for programming, logic processing, text generation, visual analysis, video processing, and audio applications
• The defense tech company intends to deploy these models throughout its AI infrastructure, defense automation software, and aerospace technology projects
• Rocket One maintains proprietary rights to advanced nanomagnetic and spintronic semiconductor innovations

---

Rocket One (RKTO) revealed on Wednesday that it has successfully joined the SpaceXAI API program, securing the defense and AI technology company access to SpaceXAI’s cutting-edge multimodal artificial intelligence systems. Shares responded with a significant rally of approximately 24%, reaching the $0.80 level.

Rocket One Inc., RKTO

With a modest market capitalization of $15.35 million, the firm now gains entry to SpaceXAI’s comprehensive suite of AI models spanning programming assistance, logical reasoning, text generation, image processing, video analysis, and voice recognition technologies.

According to the company, these advanced capabilities will undergo testing and integration throughout multiple operational domains, including core AI infrastructure development, autonomous military software systems, and space-based computing platforms. This represents an ambitious roadmap for an organization of Rocket One’s current scale.

Chief Executive Officer Robb Knie emphasized that securing access to leading-edge foundation models represents a critical milestone as the organization constructs what it characterizes as an AI-centric platform tailored for the defense and aerospace sectors.

The SpaceXAI partnership is designed to complement Rocket One’s current technology portfolio, which features proprietary nanomagnetic and spintronic semiconductor innovations.

The firm is actively engineering what it terms radiation-resistant AI processor technology — specifically architected to operate reliably in low-Earth orbital environments, deep-space missions, and defense scenarios where conventional silicon chips experience degradation.

This nanomagnetic matrix multiplication architecture serves as a specialized hardware accelerator optimized for machine learning computations. The technology remains in development, having not yet been manufactured as a complete integrated circuit or tested in actual space conditions.

Latest Developments at Rocket One

The SpaceXAI partnership announcement follows several months of significant corporate activity. During June, Rocket One disclosed approximately $8.4 million in available cash resources, generated through an at-the-market equity offering program.

The organization also unveiled Swarm Stage AI, an autonomous drone fleet defense system designed for military agencies, government entities, and security organizations. The platform leverages technology obtained through the acquisition of SkyStage, a commercial drone coordination company.

Regarding leadership expansion, Rocket One appointed retired Colonel Robert “Shane” Kimbrough — a veteran NASA astronaut — to its Space Advisory Board.

Additionally, the company recently satisfied Nasdaq’s minimum share price standards after sustaining a closing price above $1.00 for ten straight trading sessions.

Analyst Perspectives

A single analyst has established a $5.00 price objective for RKTO. Projections indicate potential earnings of $8.21 per share for the 2026 fiscal year, though this estimate appears notably elevated relative to the company’s present share price and overall valuation.

InvestingPro data suggests the stock may be trading below its intrinsic value according to their Fair Value analysis framework. Nevertheless, shares remain down 44% year-over-year despite Wednesday’s substantial gains.

The organization’s biotechnology portfolio — encompassing research programs designated HT-001, HT-KIT, HT-ALZ, and a GDNF-focused metabolic initiative — operates through a fully owned subsidiary, maintained separately from primary defense and aerospace operations.

As of Wednesday morning trading, RKTO was changing hands at $1.0001, representing a daily increase of $0.1977.

The post Rocket One (RKTO) Stock Soars 24% Following SpaceXAI API Program Acceptance appeared first on Blockonomi.